Neuregulin-1 high-producer genotype is associated with a decreased risk of admission to the neonatal intensive care unit

« Previous Next »Early Human Development
Volume 86, Issue 5 , Pages 299-304, May 2010

Elizabeth P. Pleickhardt
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
Andrew Celandine
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
Jonathan M. Davis
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
Minghua Chen
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
Peter Schürmann
- Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany
Thilo Dörk
- Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany
Christiane E.L. Dammann
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
- Department of Pediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany
Olaf Dammann
- Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
- Perinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany
- Neuroepidemiology Unit, Children's Hospital, Boston, MA, USA
- Corresponding Author. Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Box 854, 750 Washington St., Boston, MA 02111, USA. Tel.: +1 617 636 0240; fax: +1 617 636 3309.